HHS plan to speed drug R&D won’t remove ‘self-inflicted’ delays

HHS plan to speed drug R&D won’t remove ‘self-inflicted’ delays is a pharma and life sciences industry update from PharmaVoice. The story may affect commercial strategy, market access planning, stakeholder engagement, competitive positioning, and near-term monitoring for pharmaceutical and biotech teams.

Kelly Bilodeau · 2026-07-08

U.S. clinical trials continue to lose ground to China, but is Operation Trailblazer enough to help America catch up?

Source: PharmaVoice